{"id":"https://openalex.org/W4397012941","doi":"https://doi.org/10.1158/1557-3265.bladder24-ia007","title":"Abstract IA007: Tumor HLA-E expression and cytomegalovirus infection modulate NK cell activity in human bladder cancer","display_name":"Abstract IA007: Tumor HLA-E expression and cytomegalovirus infection modulate NK cell activity in human bladder cancer","publication_year":2024,"publication_date":"2024-05-17","ids":{"openalex":"https://openalex.org/W4397012941","doi":"https://doi.org/10.1158/1557-3265.bladder24-ia007"},"language":"en","primary_location":{"id":"doi:10.1158/1557-3265.bladder24-ia007","doi":"https://doi.org/10.1158/1557-3265.bladder24-ia007","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1557-3265.bladder24-ia007","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083361833","display_name":"Amir Horowitz","orcid":"https://orcid.org/0000-0003-3100-2810","observed_orcids":["https://orcid.org/0000-0003-3100-2810","https://orcid.org/0000-0003-4602-1440"]},"institutions":[{"id":"https://openalex.org/I98704320","display_name":"Icahn School of Medicine at Mount Sinai","ror":"https://ror.org/04a9tmd77","country_code":"US","type":"education","lineage":["https://openalex.org/I1320796813","https://openalex.org/I98704320"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Amir Horowitz","raw_affiliation_strings":["1Icahn School of Medicine at Mount Sinai, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Icahn School of Medicine at Mount Sinai, New York, NY","institution_ids":["https://openalex.org/I98704320"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5083361833"],"corresponding_institution_ids":["https://openalex.org/I98704320"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"30","issue":"10_Supplement","first_page":"IA007","last_page":"IA007"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.9800000190734863,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11020","display_name":"Immune Cell Function and Interaction","score":0.9800000190734863,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10981","display_name":"Cytomegalovirus and herpesvirus research","score":0.016599999740719795,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cytomegalovirus-reactivation","display_name":"cytomegalovirus reactivation","score":0.9190000295639038},{"id":"https://openalex.org/keywords/hla-e","display_name":"HLA-E","score":0.7210000157356262},{"id":"https://openalex.org/keywords/natural-killer-cells","display_name":"natural killer cells","score":0.8690000176429749},{"id":"https://openalex.org/keywords/nkg2c","display_name":"NKG2C","score":0.9539999961853027},{"id":"https://openalex.org/keywords/adaptive-nk-cells","display_name":"adaptive NK cells","score":0.7950000166893005},{"id":"https://openalex.org/keywords/bladder-cancer","display_name":"bladder cancer","score":0.8029999732971191},{"id":"https://openalex.org/keywords/non-muscle-invasive-bladder-cancer","display_name":"non-muscle-invasive bladder cancer","score":0.9810000061988831},{"id":"https://openalex.org/keywords/bcg-therapy","display_name":"BCG immunotherapy","score":0.8289999961853027},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.843999981880188},{"id":"https://openalex.org/keywords/viral-infection-and-cancer","display_name":"viral infection and cancer","score":0.3889999985694885},{"id":"https://openalex.org/keywords/immunotherapy-response-biomarkers","display_name":"immunotherapy response biomarkers","score":0.5180000066757202}],"concepts":[{"id":"https://openalex.org/C188280979","wikidata":"https://www.wikidata.org/wiki/Q911125","display_name":"Human leukocyte antigen","level":3,"score":0.6692075729370117},{"id":"https://openalex.org/C2777732132","wikidata":"https://www.wikidata.org/wiki/Q6946","display_name":"Cytomegalovirus","level":5,"score":0.6480590105056763},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.625979483127594},{"id":"https://openalex.org/C2779820661","wikidata":"https://www.wikidata.org/wiki/Q6929","display_name":"Human cytomegalovirus","level":3,"score":0.575442373752594},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5443515181541443},{"id":"https://openalex.org/C2780352672","wikidata":"https://www.wikidata.org/wiki/Q504775","display_name":"Bladder cancer","level":3,"score":0.48020800948143005},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4539291262626648},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.43394166231155396},{"id":"https://openalex.org/C2776409557","wikidata":"https://www.wikidata.org/wiki/Q149348","display_name":"Herpesviridae","level":4,"score":0.37601789832115173},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.370799720287323},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3510870337486267},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.3045167326927185},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.21939516067504883},{"id":"https://openalex.org/C2780727368","wikidata":"https://www.wikidata.org/wiki/Q1928978","display_name":"Viral disease","level":3,"score":0.18104127049446106},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.13215625286102295}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1557-3265.bladder24-ia007","doi":"https://doi.org/10.1158/1557-3265.bladder24-ia007","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1557-3265.bladder24-ia007","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7130423211","https://openalex.org/W4415751533","https://openalex.org/W3193490473","https://openalex.org/W4399425840","https://openalex.org/W1822254253","https://openalex.org/W2953549125","https://openalex.org/W4402772579","https://openalex.org/W4213061089","https://openalex.org/W3212881880","https://openalex.org/W2590066055"],"abstract_inverted_index":{"Abstract":[0],"The":[1],"intersection":[2],"of":[3,39,80,82,117,143,148,170,179,233,293,304,311,321,344,427,455],"viral":[4,126],"infections":[5],"and":[6,26,87,120,137,161,191,219,255,290,297,336,348,363,374,430,441],"cancer":[7,134,152,451],"therapy":[8,239,284,300,335],"presents":[9],"a":[10,95,125,221,231,257,278,356,420],"complex":[11],"landscape":[12],"for":[13,195,227,247,358,367,387,396],"immunotherapy":[14,228],"strategies,":[15],"particularly":[16],"in":[17,33,97,110,145,186,262,287,307,325,412,425,431,448],"solid":[18,34,100,388,410],"tumors,":[19],"where":[20],"treatments":[21,205],"such":[22],"as":[23,46,58,73,154,156,350,352,390,392],"systemic":[24,415],"chemotherapy":[25],"targeted":[27],"radiation":[28],"are":[29,36,183],"standard.":[30],"Largely":[31],"unexplored":[32],"tumors":[35,295,389],"the":[37,77,168,176,212,215,319,361,456,464],"effects":[38,52,61],"human":[40,449],"herpes":[41],"virus-5":[42],"(HHV-5)":[43],"also":[44],"known":[45],"HCMV":[47,67,91,164,189,250,253,263,405],"that":[48,128,174,203,379],"imprints":[49],"both":[50,146],"lifelong":[51],"on":[53,62,133,460],"natural":[54],"killer":[55],"(NK)":[56],"cells":[57,64,173,226,276,324,340,382],"well":[59,155,351,391],"progressive":[60],"T":[63],"with":[65,99,159,271],"aging.":[66],"is":[68,92,202,407],"an":[69],"extremely":[70],"successful":[71],"virus":[72,197],"it":[74,417],"rarely":[75],"kills":[76],"host":[78],"outside":[79],"settings":[81,147],"compromised":[83],"immunity,":[84],"e.g.":[85],"transplantation":[86],"advanced":[88],"HIV-1":[89],"infection.":[90],"not":[93],"considered":[94],"comorbidity":[96,422],"patients":[98,235,265,270],"tumors.":[101,308],"Our":[102,199,376],"group":[103],"has":[104],"identified":[105],"reactivated":[106],"cytomegalovirus":[107,442],"(HCMV),":[108],"found":[109],"bladder":[111,151,313,327,362,450],"tissues":[112,411],"post":[113],"treatment,":[114],"including":[115],"infection":[116,144,165,443],"monocytes,":[118],"fibroblasts,":[119],"even":[121],"tumor":[122,216,316],"cells,":[123],"suggesting":[124,355],"influence":[127],"extends":[129],"beyond":[130],"traditional":[131],"perspectives":[132],"treatment":[135,428],"resistance":[136],"response.":[138],"We":[139],"have":[140,192],"observed":[141,256],"spread":[142],"BCG-treated":[149],"non-muscle-invasive":[150],"(NMIBC)":[153],"MIBC":[157],"treated":[158],"gemcitabine":[160],"cisplatin":[162],"chemotherapy.":[163],"leads":[166],"to":[167,188,223,282,333,360,385,414,423],"development":[169],"\u201cadaptive\u201d":[171],"NK":[172,225,275,323,339,381,401,445],"express":[175],"activating":[177],"isoform":[178],"NKG2A:":[180],"NKG2C,":[181],"which":[182],"likely":[184],"expanded":[185],"response":[187,281,384,413],"reactivation":[190,406],"established":[193],"functions":[194],"controlling":[196],"reactivation.":[198],"central":[200],"hypothesis":[201],"certain":[204],"may":[206,418],"reactivate":[207],"HCMV,":[208],"potentially":[209],"greatly":[210],"altering":[211],"biology":[213],"within":[214],"microenvironment":[217],"(TME)":[218],"providing":[220],"framework":[222],"exploit":[224],"strategies.":[229],"In":[230],"cohort":[232],"NMIBC":[234],"(N=90)":[236],"receiving":[237],"BCG":[238,283,299,334],"at":[240],"Mount":[241],"Sinai,":[242],"we":[243],"profiled":[244],"patients\u2019":[245],"serum":[246],"HCMV-IgG":[248],"(N=47":[249],"seropositive;":[251],"N=43":[252],"seronegative)":[254],"significantly":[258],"improved":[259],"recurrence-free":[260],"survival":[261],"seropositive":[264],"(HR=0.58,":[266],"p=0.03).":[267],"Further,":[268,309],"HCMV-seropositive":[269],"circulating":[272],"NKG2C+":[273],"adaptive":[274,322,338,380],"experienced":[277],"near":[279],"perfect":[280],"(p=0.0002).":[285],"Strikingly,":[286],"situ":[288],"imaging":[289],"RNAscope":[291],"analyses":[292],"patient":[294],"before":[296],"after":[298,315,331],"revealed":[301],"strong":[302],"presence":[303,320],"active":[305],"viremia":[306],"analysis":[310],"on-treatment":[312],"biopsies":[314],"resection":[317],"demonstrated":[318],"HCMV+":[326],"tissues,":[328],"but":[329],"only":[330],"exposure":[332],"tissue-derived":[337],"expressed":[341],"high":[342],"levels":[343],"chemokine":[345],"receptors,":[346],"CXCR3":[347],"CXCR4":[349],"tissue-residency":[353],"markers,":[354],"mechanisms":[357],"trafficking":[359],"taking":[364],"up":[365],"residence":[366],"subsequent":[368],"antitumor":[369],"control":[370],"against":[371],"recurrence.":[372],"Impact":[373],"Translation:":[375],"findings":[377],"suggest":[378],"mediate":[383],"immunotherapies":[386],"provide":[393],"preclinical":[394],"models":[395],"adoptive":[397],"transfer":[398],"therapies":[399],"targeting":[400],"cells.":[402],"Additionally,":[403],"if":[404],"widespread":[408],"across":[409],"therapies,":[416],"prove":[419],"critical":[421],"consider":[424],"design":[426],"strategies":[429],"clinical":[432],"trials.":[433],"Citation":[434],"Format:":[435],"Amir":[436],"Horowitz.":[437],"Tumor":[438],"HLA-E":[439],"expression":[440],"modulate":[444],"cell":[446],"activity":[447],"[abstract].":[452],"In:":[453],"Proceedings":[454],"AACR":[457],"Special":[458],"Conference":[459],"Bladder":[461],"Cancer:":[462],"Transforming":[463],"Field;":[465],"2024":[466],"May":[467],"17-20;":[468],"Charlotte,":[469],"NC.":[470],"Philadelphia":[471],"(PA):":[472],"AACR;":[473],"Clin":[474],"Cancer":[475],"Res":[476],"2024;30(10_Suppl):Abstract":[477],"nr":[478],"IA007.":[479]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1}],"updated_date":"2026-10-09T09:14:12.587421","created_date":"2024-05-18T00:00:00"}